Startseite>>Tricyclic amide linker resin (DL-form) (200-400 mesh, 0.5-0.8 mmol/g)

Tricyclic amide linker resin (DL-form) (200-400 mesh, 0.5-0.8 mmol/g)

Katalog-Nr.GA23642

Ramage resin is highly suitable for the preparation of peptide amides by the Fmoc-strategy and is recommended for C-terminal Phe, Tyr and Ile. Cleavage has been performed with 50 % TFA in CH?Cl? or 95% aqueous TFA. Scavengers may be required. Tricyclic amide linker resin has been used for the synthesis of fluorogenic substrates for continuous assay of aminopeptidase P. glpbio additionally offers the Ramage amide linker (Q-2745) to be coupled to other types of carrier resin.

Products are for research use only. Not for human use. We do not sell to patients.

Tricyclic amide linker resin (DL-form) (200-400 mesh, 0.5-0.8 mmol/g) Chemische Struktur

Größe Preis Lagerbestand Menge
1g
143,00 $
Auf Lager
5g
543,00 $
Auf Lager
25g
2.146,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Ramage resin is highly suitable for the preparation of peptide amides by the Fmoc-strategy and is recommended for C-terminal Phe, Tyr and Ile. Cleavage has been performed with 50 % TFA in CHCl or 95% aqueous TFA. Scavengers may be required. Tricyclic a

Bewertungen

Review for Tricyclic amide linker resin (DL-form) (200-400 mesh, 0.5-0.8 mmol/g)

Average Rating: 5 ★★★★★ (Based on Reviews and 27 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Tricyclic amide linker resin (DL-form) (200-400 mesh, 0.5-0.8 mmol/g)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.